Literature DB >> 3341694

Ranitidine and bradycardia.

W S Johnson, D R Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3341694     DOI： 10.7326/0003-4819-108-3-493

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

1.  Haemodynamic effects of roxatidine, an H2-receptor antagonist.

Authors:  A Halabi; A Nokhodian; W Kirch
Journal:  Clin Investig       Date:  1992-02

Review 2.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

3.  Syncope caused by ranitidine-induced increase in A-V block.

Authors:  M Radhamanohar
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

4.  Ranitidine-induced bradycardia in a neonate--secondary to congenital long QT interval syndrome?

Authors:  P Alliët; E Devos
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

Review 5.  Side effects of ranitidine.

Authors:  T Vial; C Goubier; A Bergeret; F Cabrera; J C Evreux; J Descotes
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 6.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

7.  Ranitidine-induced bradycardia in a neonate--a first report.

Authors:  E Nahum; O Reish; N Naor; P Merlob
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.